Wohlfahrt, Peter

Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study

Stehlik, J., Schmalfuss, C., Bozkurt, B., Nativi-Nicolau, J., Wohlfahrt, P., Wegerich, S., Rose, K., Ray, R., Schofield, R., Deswal, A., et al. (2020) · Circulation Heart Failure

Heart Failure Treatment and ManagementNon-Invasive Vital Sign Monitoring

Cited by 333

Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V

Ferrannini, G., De Bacquer, D., De Backer, G., Kotseva, K., Mellbin, L., Wood, D., Rydén, L., collaborators, E. V., Gale, C. P., Beleslin, B., et al. (2020) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 75

The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease

Benes, J., Kotrc, M., Wohlfahrt, P., Conrad, M. J., Franekova, J., Jabor, A., Lupinek, P., Kautzner, J., Melenovsky, V., & Jarolim, P. (2019) · Canadian Journal of Cardiology

GDF15 and Related BiomarkersHeart Failure Treatment and Management

Cited by 42